Europe style for Clindamycin HCL 21462-39-5 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore
Europe style for Clindamycin HCL 21462-39-5 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 5kg/month
Order(MOQ): 10g
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: vial
Package size: 10g/drum
Safety information: UN 2811 6.1/ PG 1
Description
Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity.
It is given intravenously to treat upper gastro-intestinal cancers (e.g. esophageal carcinoma), anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours.
Mitomycin C is used in cancers, particularly bladder cancers and intraperitoneal tumours.
Mitomycin C is used in eye surgery where mitomycin C 0.02% is applied topically to prevent scarring during glaucoma filtering surgery and to prevent haze after PRK or LASIK; mitomycin C has also been shown to reduce fibrosis in strabismus surgery.
Mitomycin C is used in esophageal and tracheal stenosis where application of mitomycin C onto the mucosa immediately following dilatation will decrease re-stenosis by decreasing the production of fibroblasts and scar tissue.
Specification (USP/EP)
Item |
Specification |
Appearance |
Blue-violet, crystalline powder |
Identification |
IR: The IR spectrum of the sample corresponds to the spectrum of reference standard |
HPLC: The retention time of the major peak of the sample solution corresponds to that of the standard solution, as obtained in the Assay | |
pH |
6.0~7.5 |
Water |
Not more than 2.5% |
Crystallinity |
Should conforms |
Related Substances | |
Albomitomycin C
(EP Impurity D) |
Not more than 0.5% |
Mitomycin B
(EP Impurity C) |
Not more than 0.5% |
Cinnamamide
(EP Impurity A) |
Not more than 0.5% |
Mitomycin A
(EP Impurity B) |
Not more than 0.5% |
Any Individual Unspecified Impurity |
Not more than 0.5% |
Total Impurities |
Not more than 2.0% |
Residual Solvents | |
Methanol |
Not more than 3000 ppm |
Methylene Chloride |
Not more than 600 ppm |
Ethyl Acetate |
Not more than 5000 ppm |
Bacterial Endotoxins |
Not more than 10 EU/mg |
Assay |
Not less than 970 mg/g of Mitomycin |
Product detail pictures:

Related Product Guide:
With this motto in mind, we have become one of the most technologically innovative, cost-efficient, and price-competitive manufacturers for Europe style for Clindamycin HCL 21462-39-5 - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore , The product will supply to all over the world, such as: Costa Rica, Mali, Hongkong, If you need any of our products, or have other items to be produced, please send us your inquiries, samples or detailed drawings. Meanwhile, aiming to develop into an international enterprise group, we look forward to receiving offers for joint ventures and other cooperative projects.

The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
